TRINITY BIOTECH PLC TRIB

Latest FY: 2025 Healthcare Medical Devices
Market Price $12.07
Market Cap $244.43M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-29.0% YoY
$43.78M
3-Yr CAGR: -16.3%
Net Income ↓-17.6% YoY
-$37.38M
Net Margin: -85.4%
Free Cash Flow ↑69.3% YoY
-$434.00K
FCF Yield: -0.18%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-35.5%
ROA: -35.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TRIB)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $99.6M $43.5M $-100.6M 0.00% $-1.2M
FY 2017 $99.1M -0.5% $41.9M $-40.3M +60.0% 0.00% $-0.8M $-5.7M
FY 2018 $97.0M -2.1% $41.4M $-22.1M +45.1% 0.00% $0.4M $-7.1M -25.2%
FY 2019 $90.4M -6.8% $38.1M $-28.9M -30.9% 0.00% $-0.0M $-2.1M +70.0%
FY 2020 $102.0M +12.8% $48.6M $-6.4M +77.9% 0.00% $-1.0M $-4.2M -94.3%
FY 2021 $93.0M -8.8% $38.1M $0.9M +113.7% 0.00% $-1.6M $-3.4M +17.3%
FY 2022 $74.8M -19.6% $22.0M $-41.0M -4,786.7% 0.00% $0.0M $-1.1M +68.3%
FY 2023 $57.1M -23.6% $19.4M $-24.0M +41.4% 0.00% $-0.3M $-1.1M -2.7%
FY 2024 $61.6M +7.9% $21.4M $-31.8M -32.4% 0.00% $-1.0M $-1.4M -26.9%
FY 2025 $43.8M -29.0% $16.9M $-37.4M -17.6% 0.00% $-0.3M $-0.4M +69.3%
$

Valuation

Market Price $12.07
Market Cap $244.43M
Enterprise Value $239.29M
P/E Ratio N/A
P/B Ratio 2.32
FCF Yield -0.18%
Dividend Yield 0.00%
Shares Outstanding 20,250,900
%

Profitability & Margins

Gross Margin 38.57%
Operating Margin -84.91%
Net Margin -85.36%
Return on Equity (ROE) -35.54%
Return on Assets (ROA) -35.54%
Asset Turnover 0.42x
Revenue 3-Yr CAGR -16.34%
🛡️

Financial Health & Liquidity

Current Ratio 1.00
Cash Ratio 0.14
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $5.14M
Total Debt N/A
Book Value / Share $5.19
💧

Cash Flow Efficiency

Operating Cash Flow -$346.00K
Capital Expenditures (CapEx) $88.00K
Free Cash Flow -$434.00K
OCF / Revenue -0.79%
FCF / Revenue -0.99%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $5.19
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $105.17M
Total Liabilities N/A
Stockholders' Equity $105.17M
Current Assets $35.90M
Current Liabilities $35.94M